Table 2 Demographic and neuropsychological characteristics of study participants before and during the pandemic.

Demographic characteristics

 Subjects

39

39

 Gender (male/female)

8/31

8/31

 Age (years)

67.87

5.76

70.72

5.62

 Education (years)

13.28

2.14

Neuropsychological assessment

 MMSE

29.23

0.86

29.38

0.77

 ≥ 23.8

 ACE-R

93.28

3.44

94.38

2.86

 ≥ 79 (< 75 years old);

 ≥ 60 (> 75 years old)

 MoCA

25.23

2.17

26.36

2.62

 ≥ 17.363

 CFI self-report

2.81

1.72

 CFI partner-report

1.64

1.37

 RMT—15 instant words

44.79

8.92

44.18

7.61

 ≥ 28.53

 RMT—15 delayed words

9.38

2.51

9.56

2.94

 ≥ 4.69

 TMT—part A

38.97

12.09

39.59

13.63

 ≤ 94

 TMT—part B

89.97

24.55

93.74

37.47

 ≤ 283

 TMT B-A

51.01

19.94

54.10

31.90

 ≤ 187

 TT

33.56

2.02

34.79

0.99

 ≤ 29

Neuropsychiatric assessment

 AES

2.36

3.01

10.97

6.95

 ≤ 14

 BDI

7.33

5.71

7.36

6.50

 ≤ 9

 DIS

1.77

1.79

2.23

1.66

 ≤ 16.9

 HARS

4.97

3.62

8.15

5.16

 ≤ 14

 MAS

1.54

1.99

1.56

1.77

 ≤ 15

Physical status

 Frailty phenotype

0.33

0.57

0.44

0.63

0

 CIRS—severity index

1.25

0.82

1.36

0.19

 CIRS—comorbidity index

0.15

0.67

1.49

0.98